Glucose Control in Open Heart Surgery
Primary Purpose
Hyperglycaemia During Perioperative Period, Heart Valve Diseases, Ventricular Dysfunction
Status
Completed
Phase
Phase 1
Locations
Brazil
Study Type
Interventional
Intervention
human regular insulin
Sponsored by
About this trial
This is an interventional treatment trial for Hyperglycaemia During Perioperative Period focused on measuring hyperglycaemia, open heart surgery, intensive care unit
Eligibility Criteria
Inclusion Criteria: adult more than 21 years old open heart surgery with cardiopulmonary bypass Exclusion Criteria: renal dysfunction reoperation use of inotropic support neurological dysfunction chronic pulmonary obstructive disease emergency or urgency
Sites / Locations
- Heart Institute, Hospital of Clinics, São Paulo University Medical School
Outcomes
Primary Outcome Measures
Duration of intubation
ICU length
Blood transfusion
Infection rate
Renal dysfunction
Neurological dysfunction
Hospital length
Mortality
Secondary Outcome Measures
Length of surgery
Length of cardiopulmonary bypass
Physical status
EuroSCORE
Parsonnet
Canadian Multicenter index
Full Information
NCT ID
NCT00370643
First Posted
August 30, 2006
Last Updated
February 18, 2009
Sponsor
University of Sao Paulo
1. Study Identification
Unique Protocol Identification Number
NCT00370643
Brief Title
Glucose Control in Open Heart Surgery
Official Title
Intensive Glucose Control Versus Conventional:Tendency Of Better Clinical Outcome In Open Heart Surgery
Study Type
Interventional
2. Study Status
Record Verification Date
February 2009
Overall Recruitment Status
Completed
Study Start Date
October 2002 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
November 2004 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
University of Sao Paulo
4. Oversight
5. Study Description
Brief Summary
The purpose of the study is to seek if there is difference to state glucose level in 80-120mg/dl or 200mg/dl in patients submitted to open heart surgery
Detailed Description
Hyperglycaemia in the intensive care unit and perioperative period has been accused to be one of the causes of worse clinical outcome. It is known that in open heart surgeries the glucose level must be set less than 200mg/dl, but new trials had set the glucose level lower than that: 140mg/dl in some studies and even lower (80-110mg/dl). Our trial had the intention to seek if there is difference setting glucose level in 2 different ones would modifies clinical outcome.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hyperglycaemia During Perioperative Period, Heart Valve Diseases, Ventricular Dysfunction
Keywords
hyperglycaemia, open heart surgery, intensive care unit
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
98 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
human regular insulin
Primary Outcome Measure Information:
Title
Duration of intubation
Title
ICU length
Title
Blood transfusion
Title
Infection rate
Title
Renal dysfunction
Title
Neurological dysfunction
Title
Hospital length
Title
Mortality
Secondary Outcome Measure Information:
Title
Length of surgery
Title
Length of cardiopulmonary bypass
Title
Physical status
Title
EuroSCORE
Title
Parsonnet
Title
Canadian Multicenter index
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
adult more than 21 years old
open heart surgery with cardiopulmonary bypass
Exclusion Criteria:
renal dysfunction
reoperation
use of inotropic support
neurological dysfunction
chronic pulmonary obstructive disease
emergency or urgency
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jose O Costa Auler Junior, Professor
Organizational Affiliation
Heart instutute, Hospital of Clinics, São Paulo University Medical School
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Raquel PC Chan
Organizational Affiliation
Heart Institute, Hospital of Clinics, São Paulo University Medical School
Official's Role
Study Chair
Facility Information:
Facility Name
Heart Institute, Hospital of Clinics, São Paulo University Medical School
City
São Paulo
ZIP/Postal Code
05403-000
Country
Brazil
12. IPD Sharing Statement
Citations:
PubMed Identifier
11794168
Citation
van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 Nov 8;345(19):1359-67. doi: 10.1056/NEJMoa011300.
Results Reference
result
PubMed Identifier
9033300
Citation
Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997 Feb;63(2):356-61. doi: 10.1016/s0003-4975(96)01044-2.
Results Reference
result
PubMed Identifier
19142552
Citation
Chan RP, Galas FR, Hajjar LA, Bello CN, Piccioni MA, Auler JO Jr. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics (Sao Paulo). 2009;64(1):51-60. doi: 10.1590/s1807-59322009000100010.
Results Reference
derived
Learn more about this trial
Glucose Control in Open Heart Surgery
We'll reach out to this number within 24 hrs